These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 2615869)

  • 1. Antitumor activity and cross-resistance studies with Pt-ascorbato complexes.
    Hrubisko M; Balázová E; Kiss F; Kovácová J; Ujházy V
    Neoplasma; 1989; 36(6):651-7. PubMed ID: 2615869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity of four polymer bound trans-1,2-diaminocyclohexaneplatinum(II)-4-carboxyphtalate complexes tested in different model systems.
    Balázová E; Hrubisko M; Drobník J; Ujházy V
    Neoplasma; 1986; 33(6):665-70. PubMed ID: 3808121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effectivity of two diaminocyclohexane Pt-complexes.
    Balázová E; Hrubisko M; Ujházy V
    Neoplasma; 1985; 32(5):537-42. PubMed ID: 4069288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug resistance induction and cross-resistance studies with Pt-complexes.
    Hrubisko M; Balázová E; Ujházy V
    Neoplasma; 1984; 31(6):649-53. PubMed ID: 6542968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ascorbato(1,2-diaminocyclohexane):platinum(II) complexes, a new series of water-soluble antitumor drugs.
    Hacker MP; Khokhar AR; Brown DB; McCormack JJ; Krakoff IH
    Cancer Res; 1985 Oct; 45(10):4748-53. PubMed ID: 4040806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
    Siddik ZH; al-Baker S; Thai G; Khokhar AR
    Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of cytotoxicity and cellular pharmacology of 1,2-diaminocyclohexane platinum (IV) complexes mediated by axial and equatorial ligands.
    Kido Y; Khokhar AR; al-Baker S; Siddik ZH
    Cancer Res; 1993 Oct; 53(19):4567-72. PubMed ID: 8402629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axial ligands and alicyclic ring size modulate the activity and biochemical pharmacology of ammine/cycloalkylamine-platinum(IV) complexes in tumor cells resistant to cis-diamminedichloroplatinum(II) or trans-1R,2R-1S,2S-diaminocyclohexanetetrachloroplatinum(IV).
    Yoshida M; Khokhar AR; Siddik ZH
    Cancer Res; 1994 Sep; 54(17):4691-7. PubMed ID: 8062266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical and biological studies on a series of novel (trans-(1R,2R)-, trans-(1S,2S)-, and cis-1,2-diaminocyclohexane)platinum(IV) carboxylate complexes.
    Khokhar AR; al-Baker S; Shamsuddin S; Siddik ZH
    J Med Chem; 1997 Jan; 40(1):112-6. PubMed ID: 9016335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, cytotoxicity and antitumor activity of platinum(II) complexes of cyclopentanecarboxylic acid hydrazide.
    Kushev D; Gorneva G; Taxirov S; Spassovska N; Grancharov K
    Biol Chem; 1999 Nov; 380(11):1287-94. PubMed ID: 10614821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
    Schmidt W; Chaney SG
    Cancer Res; 1993 Feb; 53(4):799-805. PubMed ID: 8428361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth, flow cytometric, and karyological characterization of L1210 cell sublines resistant to various Pt derivatives.
    Hrubisko M; Kysela B; Kuliffay P
    Neoplasma; 1989; 36(4):401-10. PubMed ID: 2770927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel trans platinum complexes: comparative in vitro and in vivo activity against platinum-sensitive and resistant murine tumours.
    Goddard PM; Orr RM; Valenti MR; Barnard CF; Murrer BA; Kelland LR; Harrap KR
    Anticancer Res; 1996; 16(1):33-8. PubMed ID: 8615631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo and in vitro effectivity of some platinum complexes.
    Balázová E; Hrubisko M; Ujházy V
    Neoplasma; 1984; 31(6):641-7. PubMed ID: 6395026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of carrier ligand in platinum resistance in L1210 cells.
    Gibbons GR; Page JD; Mauldin SK; Husain I; Chaney SG
    Cancer Res; 1990 Oct; 50(20):6497-501. PubMed ID: 2208108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circumvention of platinum resistance: structure-activity relationship for homologous series of ammine/amine platinum(II) complexes in L1210 cell lines.
    Yoshida M; Khokhar AR; Siddik ZH
    Anticancer Drug Des; 1994 Oct; 9(5):425-34. PubMed ID: 7945726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical pharmacology of homologous alicyclic mixed amine platinum(II) complexes in sensitive and resistant tumor cell lines.
    Yoshida M; Khokhar AR; Siddik ZH
    Cancer Res; 1994 Jul; 54(13):3468-73. PubMed ID: 8012968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Testing antineoplastic activity of new platinum(II) and palladium(II) complex compounds].
    Malinowska K; Modranka R; Kubiak K; Mrowicka M; Klimczak A; Kedziora J; Rutkowski M
    Pol Merkur Lekarski; 2009 Jan; 26(151):57-61. PubMed ID: 19391509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA synthesis, protein synthesis and platinum content following drug administration in cis-diamminedichloroplatinum(II) -sensitive and -resistant L1210 cells transferred from in vitro to in vivo conditions.
    Hanusovská E; Ujházy V
    Neoplasma; 1987; 34(6):721-6. PubMed ID: 3431611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, physical properties, and antitumor activity of tetraplatin and related tetrachloroplatinum(IV) stereoisomers of 1,2-diaminocyclohexane.
    Anderson WK; Quagliato DA; Haugwitz RD; Narayanan VL; Wolpert-DeFilippes MK
    Cancer Treat Rep; 1986 Aug; 70(8):997-1002. PubMed ID: 3731155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.